CDEK
← All organizations

Entasis Therapeutics

For profitWebsite ↗

Also known as: ENTASIS THERAP | Entasis Therapeutics

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jun 1, 2015

First marketed drug

May 23, 2023

Last known activity

Jun 21, 2019

Acquired by Innoviva on May 23, 2022

Timeline

2010s

  1. Jun 1, 2015

    Entasis Therapeutics— Founded

2020s

  1. May 23, 2022

    Innoviva— Acquired By

  2. May 23, 2023

    sulbactam— NDA Secondary Org

  3. Dec 12, 2025

    zoliflodacin— Marketing Organization

Drugs by trial phase (9 distinct, 9 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (3)

Recent trials (9)

Details

Founded
Waltham, MA, US Jun 1, 2015
Last known activity
Jun 21, 2019